Ceritinib capsule market price comparison in 2025

Ceritinib is a targeted drug mainly used to treat non-small cell lung cancer (NSCLC) that is positive for ALK gene rearrangement. Because it specifically targets ALK mutations, ceritinib has become an important treatment option for patients with this type of lung cancer. With the domestic launch of ceritinib, patients have more treatment options, but the price issue is still the focus of many patients.

In China, ceritinib has been included in medical insurance and is on the market. Its common specification is150mg*150 capsules (each box contains 3 bottles of 50 capsules). Currently, the market price of ceritinib in China is approximately more than RMB 10,000, but the price may be affected by exchange rate fluctuations, market demand and other factors. In the case of medical insurance reimbursement, the patient's out-of-pocket portion is relatively low, but the specific costs need to refer to local medical insurance policies and drug reimbursement conditions.

Compared with the domestic market, the selling price of ceritinib abroad is slightly different. The pricing of original drugs in overseas markets is similar to that in China, usually within the range of more than RMB 10,000. However, when patients choose to purchase imported drugs, they need to consider additional costs such as import taxes and logistics, which may result in a different final payment. It is worth noting that Novartis of Switzerland is the manufacturer of ceritinib. Its original drug is sold in many countries and regions around the world and has received high recognition.

Generic drugs of ceritinib that can reduce treatment costs have also emerged overseas. Taking the Lao version of generic drugs as an example, the specification is 150mg*60 pills, and each box is priced at more than 1,000 yuan. Although the ingredients of generic drugs are basically the same as those of original drugs, you need to be careful when choosing to ensure that the selected generic drugs meet the quality standards to avoid affecting the therapeutic effect due to low prices.

Reference materials:https://go.drugbank.com/drugs/DB09063